Protocol Design White Papers & Case Studies

1. Human-Centered RTSM Design Enhances Data, Safety, And Operations 12/5/2025

   Uncover how this human-centered approach to RTSM prioritizes user experience (UX) and interface design (UI) to reduce complexity, minimize errors, and improve compliance.

2. User Acceptance Testing (UAT): Keeping Trials On Track 12/5/2025

   Validate endpoint performance and security before deployment with structured UAT that reduces risk, ensures compliance, and enhances user experience through real-world testing.

3. Endpoint Clinical RTSM: Getting The Job Done 12/5/2025

   Explore how a Job-to-be-Done (JTBD)-focused RTSM approach reduces delays, optimizes costs, and accelerates trial success through predictive intelligence and streamlined global workflows.

4. De-Risk Randomization With The Endpoint Biostatistical Approach 12/5/2025

   With over 15 years of RTSM experience, high-touch quality management, and forward-thinking technology, our solutions enhance trial speed, accuracy, and operational efficiency.

5. Elosity: Next-Generation RTSM 12/5/2025

   With its agile, user-centric approach, Elosity empowers sponsors, sites, and operational teams to manage clinical programs on their terms while meeting the demands of modern clinical research.

6. Smarter Oversight, Earlier Action 11/17/2025

   When risk-based oversight is reduced to a compliance checkbox, critical signals can be missed and escalate into systemic issues.

7. A New Blueprint For Transforming Feasibility And Recruitment 10/20/2025

   Clinical trials often fail due to poor feasibility planning. A new AI-powered approach bridges protocol design with real-world patient access to improve enrollment success.

8. Streamlining Clinical Trial Start-Up In Australia 10/20/2025

   Gain a comprehensive overview of how sponsors can accelerate clinical trial start-up in Australia, leveraging the nation’s unique strengths as a global hub for clinical research.

9. Purposed-Built For ADC Development 10/17/2025

   Bispecific ADCs are reshaping cancer care. Early-phase development is critical, requiring agile CRO support, scientific depth, and real-time data to guide biotech sponsors toward long-term success.

10. Delivering A Registrational GI Trial Through Ongoing Protocol Shifts 10/17/2025

    A biotech developing bispecific antibodies partnered with a flexible CRO to launch its first U.S. GI oncology trial, requiring strategic insight and full-service clinical support.